Why Is Vir Biotechnology Stock Falling Friday?

Vir Biotechnology, Inc. (NASDAQ:VIR) stock fell in Friday’s premarket trading after the clinical-stage biopharmaceutical company priced a $150 million public stock offering at $10 per share, raising concerns about shareholder dilution. $150 Million Equity Offering Vir Biotechnology priced 15 million common shares at $10 each, expecting gross proceeds of $150 million before underwriting discounts, commissions, and expenses. The company granted...